Basal Cell Carcinoma

AiViva Biopharma has completed a phase 1/2 trial of AIV001, a nonsurgical treatment for basal cell carcinoma, the company announced in a press release.

A device using elastic-scattering spectroscopy and artificial intelligence may assist primary care physicians in the quick and accurate detection of skin cancer, according to a study.

Specific groups may experience less pain during anesthetic facial injections when a 34-gauge needle is used vs. a 33-gauge needle, according to a study.

Patients with metastatic basal cell carcinoma experiencing distant organ involvement have worse outcomes than patients with nodal involvement, according to a study.

The Veterans Health Administration’s Care Assessment Need tool may be able to predict the life expectancy of veterans, helping facilitate conversation about treatment for basal cell carcinoma, according to a study.

In this edition, M-PDT efficacy similar to isotretinoin in acne vulgaris; Spitz neoplasm diagnosis in adults; immunotherapy treatment shows promise in basal cell carcinoma and more.

Verrica Pharmaceuticals Inc. has reported lesion clearance data from part one of an ongoing phase 2 study of VP-315 for the treatment of basal cell carcinoma, according to a press release from Verrica’s licensing partner, Lytix Biopharma.

When used in tandem with clinical and dermoscopic examination, optical coherence tomography significantly improved the ability to detect recurrent or residual basal cell carcinomas after topical treatment, according to a study.

Almirall and the Centre for Genomic Regulation have entered into a research collaboration to develop and characterize novel preclinical models for the identification of new nonmelanoma skin cancer treatments, according to a press release.

Topical photodynamic therapy and methyl aminolevulinate, marketed as Metvix, displayed effectiveness and good cosmetic outcomes in the treatment of basal cell carcinomas following surgery, according to a study.